Select for export Will psilocybin lose its magic in the clinical setting? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/20451253221090822 PubMed 35480296 Copy citation Copy BibTeX Unknown journal 2022-04-21 Hayes C, Wahba M, Watson S. Europe PMC Published psilocybin DepressionReview ArticleHealthcare Workers Clinical Trial More
Select for export Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/molecules27082520 PubMed 35458717 Copy citation Copy BibTeX Unknown journal 2022-04-13 Lowe H, Toyang N, Steele B, Grant J, Ali A, Gordon L Europe PMC Published psilocybin DepressionAnxietyAddiction Review Article More
Select for export Increased global integration in the brain after psilocybin therapy for depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41591-022-01744-z PubMed 35411074 Copy citation Copy BibTeX Nature Medicine 2022-04-10 Daws RE, Timmermann C, Giribaldi B, Sexton JD, Wall MB, Erritzoe D Europe PMC Published psilocybin DepressionBrain ImagingReceptor Pharmacology Randomized Controlled Trial More
Select for export Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel-Mediated Cardiotoxicity. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyab085 PubMed 34871422 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2022-03-31 Hackl B, Todt H, Kubista H, Hilber K, Koenig X. Europe PMC Published psilocybinpsilocin AgingClinical TrialSafety Clinical Trial More
Select for export Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fphar.2021.788155 PubMed 35431912 Copy citation Copy BibTeX Frontiers in Pharmacology 2022-03-30 Murphy R, Kettner H, Zeifman R, Giribaldi B, Kartner L, Martell J Europe PMC Published psilocybin DepressionEmotional ProcessingMystical Experience Randomized Controlled Trial More
Select for export Psilocybin-Assisted Compassion Focused Therapy for Depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyg.2022.812930 PubMed 35401294 Copy citation Copy BibTeX Frontiers in Psychology 2022-03-24 Pots W, Chakhssi F. Europe PMC Published psilocybin DepressionClinical Trial Clinical Trial More
Select for export Demystifying Psychedelic Treatments in Psychiatry: Is Ego Dissolution the Solution? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2022.04.4.35 Copy citation Copy BibTeX Psychiatric News 2022-03-23 Michael Avissar, Adrian Jacques H. Ambrose OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export Psilocybin Combines Rapid Synaptogenic And Anti-Inflammatory Effects In Vitro Abstract available at the source but not redistributed here. Read at source. Details DOI 10.21203/rs.3.rs-1321542/v1 Copy citation Copy BibTeX Research Square 2022-03-07 Smedfors G, Glotfelty E, Kalani N, Hjelle CP, Horntvedt O, Wellfelt K Europe PMC PREPRINT (not peer reviewed) psilocybin DepressionHeadache / MigraineNeuroplasticity Animal Study More
Select for export Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.nsa.2022.100104 PubMed 40656230 Copy citation Copy BibTeX Neuroscience Applied 2022-03-06 Mertens LJ, Koslowski M, Betzler F, Evens R, Gilles M, Jungaberle A Europe PMC Published psilocybin DepressionClinical TrialSafety Clinical Trial More
Select for export Persisting decreases in state and trait anxiety post-psilocybin: A naturalistic, observational study among retreat attendees Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2022.03.02.22271743 Copy citation Copy BibTeX medRxiv 2022-03-01 Kiraga M, Kuypers KPC, Uthaug MV, Ramaekers J, Mason NL. medRxiv PREPRINT (not peer reviewed) psilocybinpsilocin AnxietyMechanism of ActionPersonality Change Observational Study More
Select for export The therapeutic potential of psilocybin: a systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/14740338.2022.2047929 PubMed 35225143 Copy citation Copy BibTeX Unknown journal 2022-03-01 van Amsterdam J, van den Brink W. Europe PMC Published psilocybin Clinical TrialRandomized Controlled TrialSystematic Review Randomized Controlled Trial More
Select for export The Use of Psilocybin in the Treatment of Psychiatric Disorders with Attention to Relative Safety Profile: A Systematic Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2022.2044096 PubMed 35225726 Copy citation Copy BibTeX Unknown journal 2022-02-27 Hodge AT, Sukpraprut-Braaten S, Narlesky M, Strayhan RC. Europe PMC Published psilocybin DepressionAnxietyAddiction Systematic Review More
Select for export Psilocybin: Characterization of the Metastable Zone Width (MSZW), Control of Anhydrous Polymorphs, and Particle Size Distribution (PSD). Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acsomega.1c06708 PubMed 35187358 Copy citation Copy BibTeX ACS Omega 2022-02-06 Kargbo RB, Sherwood AM, Meisenheimer P, Lenoch K, Abebe S. Europe PMC Published psilocybinpsilocin DepressionClinical TrialTreatment-Resistant Depression Clinical Trial More
Select for export Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7759/cureus.21944 PubMed 35273885 Copy citation Copy BibTeX Unknown journal 2022-02-04 Ziff S, Stern B, Lewis G, Majeed M, Gorantla VR. Europe PMC Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export [Are psychedelics fast acting antidepressant agents?] Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00115-021-01255-1 PubMed 35103814 Copy citation Copy BibTeX Unknown journal 2022-01-31 Gründer G, Brand M, Kärtner L, Scharf D, Schmitz C, Spangemacher M Europe PMC Published psilocybin Depression Other More
Select for export Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fphar.2021.749068 PubMed 35177979 Copy citation Copy BibTeX Unknown journal 2022-01-26 Markopoulos A, Inserra A, De Gregorio D, Gobbi G. Europe PMC Published psilocybin DepressionAnxietyNeuroplasticity Review Article More
Select for export Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/a-1714-9097 PubMed 35045580 Copy citation Copy BibTeX Unknown journal 2022-01-18 Sakurai H, Yonezawa K, Tani H, Mimura M, Bauer M, Uchida H. Europe PMC Published psilocybin DepressionMechanism of ActionClinical Trial Systematic Review More
Select for export Psilocybine vergeleken met escitalopram bij depressie Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Pure Amsterdam UMC 2022-01-16 Jurriaan F. M. Strous OpenAlex Published psilocybin DepressionChronic PainClinical Trial Randomized Controlled Trial More
Select for export [Psilocybin compared with escitalopram for depression]. Abstract available at the source but not redistributed here. Read at source. Details PubMed 35138714 Copy citation Copy BibTeX PubMed 2022-01-16 Strous JFM. Europe PMC Published psilocybin DepressionClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-021-06049-6 PubMed 35022823 Copy citation Copy BibTeX Unknown journal 2022-01-12 Bender D, Hellerstein DJ. Europe PMC Published psilocybin Brain ImagingAgingClinical Trial Clinical Trial More
Psilocybin-Research.com
Searchable psilocybin and psilocin bibliometric database.